1985
DOI: 10.1016/0014-2999(85)90409-1
|View full text |Cite
|
Sign up to set email alerts
|

Neuronal localization of substance P receptors in rat neostriatum

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

2
1
0

Year Published

1986
1986
2002
2002

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 4 publications
2
1
0
Order By: Relevance
“…However, neither a single administration of the low or high dose of METH altered the nigral content of SPLI. This lack of a nigral effect was consistent with previous reports that a single administration of METH does not alter nigral SPLI tissue levels (Ritter et al . 1985).…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…However, neither a single administration of the low or high dose of METH altered the nigral content of SPLI. This lack of a nigral effect was consistent with previous reports that a single administration of METH does not alter nigral SPLI tissue levels (Ritter et al . 1985).…”
Section: Discussionsupporting
confidence: 93%
“…However, neither a single administration of the low or high dose of METH altered the nigral content of SPLI. This lack of a nigral effect was consistent with previous reports that a single administration of METH does not alter nigral SPLI tissue levels (Ritter et al 1985). While the patterns of change in SPLI tissue levels confirmed the observation from the microdialysis studies that basal ganglia SP systems are differentially affected by low and high METH doses, it was not clear how the drug-induced effect on SP release (observed within 0.5-3 h) after drug exposure was linked to the changes observed in SPLI tissue levels at 12 h after treatment.…”
Section: Discussionsupporting
confidence: 92%
“…Thus, the blockade of ACh release evoked by SEP and NKA is probably due to the TTX blockade of axonal transmission following somatodendritic activation of cholinergic neurons, as has been previously reported for ACh release evoked by glutamate (Scatton and Lehmann, 1982;Arenas et al, 1990a). Furthermore, lesion studies using kainate and 6-OHDA showed that SP binding sites in the neostriatum were mainly located on striatal cell bodies and dendrites rather than on afferent nerve terminals (Ritter et al, 1985;Mantyh and Hunt, 1986). These results have been confirmed by the TTX sensitivity of 3H-dopamine release evoked by SP in striatal slices, which involves polysynaptic paths and suggests the absence of SP receptors on dopaminergic terminals (Petit and Glowinski, 1986).…”
Section: Discussionmentioning
confidence: 68%